MUSE Gold

2022

The Return of C.diff

Entrant Company

AbelsonTaylor

Category

Website - Pharmaceuticals

Client's Name

Seres Pharmaceuticals

Country / Region

United States

C. diff is considered an Urgent Health Threat by the CDC. Additionally, there are 170,000 recurrences each year following a primary episode. HCPs underestimate the devastating effects this condition has on patients’ quality of life and are frustrated because they don’t have an ideal tool to address the root cause. Since C. diff is a dire condition and patients keep coming back, the idea of horror-movie sequels is a perfect fit.
ENDLESS SEQUELS is a big, relevant campaign that shines a light on the role of the microbiome in helping to change the ending of the same predictable plot. And due to the recurring nightmare of this disease, the campaign is shaping the way doctors think about (and eventually prevent) recurrent C. diff now and into the future.

More Gold Winners
Corporate Identity
2022
MUSE Advertising Awards - Electric IT brand identity revamp

Entrant Company

Electric

Category

Corporate Identity - Corporate Identity / Other___

Country / Region

United States

Branded Content
2022
MUSE Advertising Awards - When will the COVID-19 pandemic end?

Entrant Company

McKinsey Global Publishing

Category

Branded Content - COVID-19-Related

Country / Region

United States

Video
2022
MUSE Advertising Awards - From darkness to light: Carson’s story of strength and survi

Entrant Company

SRH

Category

Video - Public Service & Activism

Country / Region

United States

Video
2022
MUSE Advertising Awards - Colin's Story: In Memory of Brianna
Starlight Children's Foundation

Entrant Company

Moonshine Agency

Category

Video - Nonprofit

Country / Region

Australia